Index
S&P 500
P/E
24.39
EPS (ttm)
3.31
Insider Own
15.22%
Shs Outstand
114.42M
Perf Week
2.42%
Market Cap
9.20B
Forward P/E
13.67
EPS next Y
5.91
Insider Trans
-0.55%
Shs Float
96.58M
Perf Month
11.10%
Enterprise Value
14.37B
PEG
1.46
EPS next Q
1.24
Inst Own
94.16%
Perf Quarter
10.45%
Income
395.00M
P/S
0.69
EPS this Y
7.57%
Inst Trans
-0.04%
Perf Half Y
4.35%
Sales
13.38B
P/B
2.83
EPS next Y
10.50%
ROA
3.63%
Perf YTD
6.85%
Book/sh
28.54
P/C
66.67
EPS next 5Y
9.34%
ROE
12.01%
52W High
89.29 -9.55%
Perf Year
15.11%
Cash/sh
1.21
P/FCF
20.67
EPS past 3/5Y
-5.75% 3.12%
ROIC
6.75%
52W Low
61.94 30.37%
Perf 3Y
3.51%
Dividend Est.
-
EV/EBITDA
12.99
Sales past 3/5Y
1.40% 5.43%
Gross Margin
29.19%
Volatility
2.39% 2.29%
Perf 5Y
5.31%
Dividend TTM
-
EV/Sales
1.07
EPS Y/Y TTM
2.92%
Oper. Margin
5.88%
ATR (14)
1.89
Perf 10Y
19.17%
Dividend Ex-Date
-
Quick Ratio
0.75
Sales Y/Y TTM
5.64%
Profit Margin
2.95%
RSI (14)
67.60
Dividend Gr. 3/5Y
- -
Current Ratio
1.36
EPS Q/Q
4.63%
SMA20
4.42%
Beta
0.81
Payout
0.00%
Debt/Eq
1.15
Sales Q/Q
6.31%
SMA50
6.65%
Rel Volume
0.34
Prev Close
81.21
Employees
25000
LT Debt/Eq
0.79
SMA200
9.72%
Avg Volume
1.38M
Price
80.76
IPO
Nov 03, 1995
Option/Short
Yes / Yes
Trades
Volume
387,187
Change
-0.55%
Date
Action
Analyst
Rating Change
Price Target Change
Jun-11-26 Upgrade BTIG Research
Neutral → Buy
$100
Apr-16-26 Initiated BTIG Research
Neutral
Apr-15-26 Initiated Citigroup
Buy
$100
Feb-23-26 Upgrade Robert W. Baird
Neutral → Outperform
$100
Dec-09-25 Initiated Barclays
Overweight
$86
Aug-26-25 Upgrade Evercore ISI
In-line → Outperform
$83
Jul-25-25 Downgrade Stifel
Buy → Hold
$75
Jul-14-25 Downgrade Robert W. Baird
Outperform → Neutral
$72
Feb-14-25 Initiated Wells Fargo
Equal Weight
$80
Jan-06-25 Upgrade BofA Securities
Underperform → Buy
$69 → $84
Dec-04-24 Initiated Mizuho
Neutral
$75
Jul-22-24 Upgrade Robert W. Baird
Neutral → Outperform
$81 → $92
Feb-26-24 Initiated Leerink Partners
Market Perform
$78
Dec-12-23 Upgrade JP Morgan
Neutral → Overweight
$71 → $82
Nov-10-23 Upgrade Stifel
Hold → Buy
$70
Aug-08-22 Upgrade UBS
Sell → Neutral
$80
Jul-21-22 Downgrade Goldman
Buy → Neutral
$93 → $85
Jun-14-22 Downgrade Robert W. Baird
Outperform → Neutral
$103 → $88
May-13-22 Resumed Credit Suisse
Outperform
$100
Jan-31-22 Initiated Morgan Stanley
Underweight
$67
Show Previous Ratings
Jun-11-26 09:38AM
May-22-26 08:00AM
May-14-26 06:30AM
May-05-26 12:51PM
10:55AM
06:06AM
Loading…
06:06AM
06:00AM
May-04-26 06:30AM
Apr-30-26 06:30AM
Apr-28-26 10:04AM
Apr-21-26 06:30AM
Apr-20-26 12:12PM
Apr-16-26 09:47AM
Apr-15-26 09:47AM
Apr-08-26 07:00AM
03:08PM
Loading…
Apr-07-26 03:08PM
Mar-30-26 03:22AM
Mar-18-26 06:30AM
Mar-10-26 06:30AM
Mar-05-26 09:40AM
Mar-03-26 06:30AM
Mar-02-26 09:45AM
Feb-24-26 03:10PM
02:03PM
01:55PM
12:32PM
11:47AM
11:10AM
09:59AM
09:30AM
08:46AM
Loading…
08:46AM
07:54AM
07:35AM
06:17AM
(Associated Press Finance)
06:00AM
Feb-23-26 09:32AM
Feb-22-26 10:09PM
Feb-19-26 10:00AM
06:30AM
Feb-17-26 10:00AM
09:19AM
06:30AM
Feb-16-26 10:39AM
Feb-06-26 06:30AM
Jan-22-26 06:30AM
Jan-20-26 09:47AM
Jan-15-26 10:00AM
Jan-14-26 11:06PM
01:27PM
Jan-13-26 09:40AM
Jan-12-26 11:15AM
09:57AM
07:00AM
Jan-06-26 11:40AM
Jan-05-26 12:37AM
Dec-29-25 06:30AM
Dec-26-25 09:50AM
Dec-23-25 04:05PM
Dec-18-25 07:54AM
Dec-09-25 04:00PM
02:37PM
Dec-04-25 11:30AM
Dec-03-25 10:31PM
Dec-02-25 08:25AM
Dec-01-25 04:34PM
07:52AM
Nov-25-25 06:30AM
Nov-13-25 09:40AM
06:30AM
Nov-12-25 07:00AM
Nov-11-25 08:26AM
Nov-07-25 09:50AM
Nov-06-25 10:21PM
09:45AM
08:00AM
(Investor's Business Daily)
Nov-04-25 04:00PM
09:30AM
08:54AM
07:10AM
06:36AM
06:10AM
(Associated Press Finance)
06:00AM
Nov-03-25 06:30AM
Nov-02-25 10:13PM
Oct-29-25 10:00AM
Oct-28-25 10:00AM
Oct-23-25 08:07AM
Oct-22-25 06:30AM
Oct-21-25 07:28AM
06:30AM
Oct-15-25 10:30AM
Oct-08-25 12:02AM
Sep-25-25 01:07PM
07:22AM
Sep-17-25 01:15PM
Sep-16-25 09:32AM
Sep-11-25 08:31AM
Sep-09-25 05:10PM
10:18AM
Aug-28-25 11:31PM
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the following segments: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. The Global Distribution and Value-Added Services segment focuses on distribution to the global dental and medical markets of national brand and corporate brand merchandise, and equipment and related technical services. The Global Specialty Products segment includes manufacturing, marketing and sales of dental implant and biomaterial products, endodontic, orthodontic and orthopedic products. The Global Technology segment focuses on development and distribution of practice management software, e-services, and other products, which are distributed to health care providers. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.
Senior VP & CFO Mr. Ronald N. South
Executive VP & COO Mr. Michael Saul Ettinger
Executive VP & Chief Strategic Officer Mr. Mark E. Mlotek
Chief Executive Officer of Global Distribution & Technology Mr. Andrea Albertini
CEO & Director Mr. Frederick M. Lowery
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Stanley M. Bergman Affiliate Jun 16 '26 Proposed Sale 81.09 16,933 1,373,097 Jun 16 05:07 PM DANIEL WILLIAM K Director May 11 '26 Buy 69.19 10,000 691,900 20,000 May 12 04:15 PM Popeck Thomas C CEO, Henry Schein Products Mar 19 '26 Sale 72.79 1,355 98,630 86,182 Mar 20 04:07 PM Popeck Thomas C Officer Mar 19 '26 Proposed Sale 72.79 1,355 98,630 Mar 19 12:30 PM KUEHN KURT P Director Mar 10 '26 Sale 78.96 2,844 224,565 15,420 Mar 11 04:08 PM KUEHN KURT P Director Mar 10 '26 Proposed Sale 78.96 2,844 224,565 Mar 10 01:42 PM MLOTEK MARK E EVP, Chief Strategic Officer Mar 04 '26 Sale 80.80 5,925 478,740 80,554 Mar 06 06:08 PM LASKAWY PHILIP A Director Mar 05 '26 Sale 80.36 2,844 228,544 21,961 Mar 06 05:08 PM LASKAWY PHILIP A Director Mar 05 '26 Proposed Sale 80.36 2,844 228,544 Mar 05 12:40 PM MLOTEK MARK E Officer Mar 04 '26 Proposed Sale 80.80 5,925 478,739 Mar 04 04:28 PM BERGMAN STANLEY M Chairman, CEO Mar 02 '26 Sale 81.31 43,812 3,562,354 383,803 Mar 03 08:18 AM Stanley M. Bergman CEO, Chairman Mar 02 '26 Proposed Sale 82.39 43,812 3,609,671 Mar 02 06:31 PM BERGMAN STANLEY M Chairman, CEO Feb 26 '26 Sale 81.01 38,346 3,106,591 427,615 Feb 27 04:31 PM BERGMAN STANLEY M Chairman, CEO Feb 27 '26 Sale 81.20 10,785 875,742 309,092 Feb 27 04:31 PM Stanley M. Bergman CEO, Chairman Feb 27 '26 Proposed Sale 81.47 10,785 878,654 Feb 27 04:22 PM Stanley M. Bergman Officer Feb 26 '26 Proposed Sale 81.91 43,046 3,525,898 Feb 26 04:25 PM Siegel Walter Officer Nov 17 '25 Proposed Sale 71.30 4,176 297,749 Nov 17 10:29 AM DANIEL WILLIAM K Director Aug 07 '25 Buy 67.08 10,000 670,800 10,000 Aug 11 04:26 PM
